Augmentation by interferon of human natural and antibody-dependent cell-mediated cytotoxicity (original) (raw)

Nature volume 277, pages 221–223 (1979)Cite this article

Abstract

LYMPHOCYTES from normal individuals may have considerable levels of cytotoxic reactivity against tumour cells, mediated by NK (natural killer) cells1. There are many similarities between NK cells and the effector cells (K cells) mediating antibody-dependent cell-mediated cytotoxicity (ADCC) against tumour target cells2,3, and they may in fact be identical cells. In vivo inoculation of rodents with viruses4,5, immunostimulants4,6–8, tumour cells4 and other interferon inducers8 results in augmented NK activity. Interferon (IF) was shown to have a major role in rapidly boosting mouse NK activity, both _in vivo_9,10 and _in vitro_9. Trinchieri and Santoli11 have suggested that IF could also augment human NK activity. However, the preparations used might have contained a variety of other lymphokines. The present study shows that IF can indeed augment human NK activity and also ADCC.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 51 print issues and online access

$199.00 per year

only $3.90 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

References

  1. Herberman, R. B. & Holden, H. T. Adv. Cancer Res. 27, 305–377 (1978).
    Article CAS Google Scholar
  2. Kay, H. D., Bonnard, G. D., West, W. H. & Herberman, R. B. J. Immun. 118, 2058–2066 (1977).
    CAS PubMed Google Scholar
  3. Santoni, A., Herberman, R. B. & Holden, H. T. J. natn. Cancer Inst. (in the press).
  4. Herberman, R. B., Nunn, M. E., Holden, H. T., Staal, S. & Djeu, J. Y. Int. J. Cancer 19, 555–564 (1977).
    Article CAS Google Scholar
  5. Welsh, R. M., Jr & Zinkernagel, R. M. Nature 268, 646–648 (1977).
    Article ADS Google Scholar
  6. Wolfe, S. A., Tracey, D. E. & Henney, C. S. Nature 262, 584–586 (1976).
    Article ADS CAS Google Scholar
  7. Wolfe, S. A., Tracey, D. E. & Henney, C. S. J. Immun. 119, 1152–1158 (1977).
    CAS PubMed Google Scholar
  8. Oehler, J. R., Lindsay, L. R., Nunn, M. E., Holden, H. T. & Herberman, R. B. Int. J. Cancer 21, 210–220 (1978).
    Article CAS Google Scholar
  9. Djeu, J. Y., Heinbaugh, J. A., Holden, H. T. & Herberman, R. B. J. Immun. (in the press).
  10. Gidlund, M. Örn, A., Wigzell, H., Senik, A. & Gresser, I. Nature 273, 759–761 (1978).
    Article ADS CAS Google Scholar
  11. Trinchieri, G. & Santoli, D. J. exp. Med. 147, 1314–1321 (1978).
    Article CAS Google Scholar
  12. Cantell, K., Hrovonen, S., Mogensen, K. E. & Pyhälä, L. In Vitro Monogr. 3, 35–38 (1973).
    Google Scholar
  13. Berg, K., Ogburn, C. A., Paucker, K., Mogensen, K. E. & Cantell, K. J. Immun. 114, 640–644 (1975).
    CAS PubMed Google Scholar

Download references

Author information

Authors and Affiliations

  1. Laboratory of Immunodiagnosis, National Cancer Institute, Bethesda, Maryland, 20014
    RONALD R. HERBERMAN, JOHN R. ORTALDO & GUY D. BONNARD

Authors

  1. RONALD R. HERBERMAN
    You can also search for this author inPubMed Google Scholar
  2. JOHN R. ORTALDO
    You can also search for this author inPubMed Google Scholar
  3. GUY D. BONNARD
    You can also search for this author inPubMed Google Scholar

Rights and permissions

About this article

Cite this article

HERBERMAN, R., ORTALDO, J. & BONNARD, G. Augmentation by interferon of human natural and antibody-dependent cell-mediated cytotoxicity.Nature 277, 221–223 (1979). https://doi.org/10.1038/277221a0

Download citation

This article is cited by